Progenics Follow Verify

Progenics Pharmaceuticals, Inc. is developing innovative medicines for oncology, with a pipeline that includes several product candidates in later-stage clinical development. Progenics has two commercial products, RELISTOR® (methylnaltrexone bromide) for opioid-induced constipation, which is partnered with Bausch Health Companies, Inc.; and AZEDRA, for the treatment of unresectable, locally advanced or metastatic pheochromocytoma or paraganglioma (rare neuroendocrine tumors of neural crest origin) who require systemic anticancer therapy.

http://www.progenics.com
Type	Public
Founded	1988
Headquarters	New York, New York
Number of employees	51-200 employees

Top 5 Recent Tweets

Date	Author	Comment
November 16, 2022	JacobPlieth	CFO summary of $LNTH evolution over 60yrs: established in microbubble & spect imaging biz. Progenics takeover took… https://t.co/ch8ct1ui1T
November 14, 2022	ivythornes1	💥Derma Progenics : Nobody Tells You The Truth https://t.co/RBpmESHkDA via @YouTube

Top 5 Lifetime News Headlines

Top Authors

• Cherry Ann Baluyut
• Chithma Kalansuriya
• Afaf Abdallah
• View all authors

Verification history

• 1,184 days ago


• 1,456 days ago


• 1,456 days ago


• View all verifications